Five biomarkers from one cerebrospinal fluid sample to stage Alzheimer's disease

被引：1

作者：

Salvado, Gemma ^{[1
]}

Hansson, Oskar ^{[1
]}

机构：

[1] Lund Univ, Lund, Sweden

来源：

NATURE AGING | 2024年 / 4卷 / 05期

关键词：

TAU;

D O I：

10.1038/s43587-024-00618-y

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Staging Alzheimer's disease on the basis of the disease's biological underpinnings might help with stratification and prognostication, both in the clinical setting and in clinical trials. We propose a staging model based on only five biomarkers, which are related to amyloid-beta and tau pathologies in different ways and can be measured with a single sample of cerebrospinal fluid.

引用

页码：623 / 624

页数：2

共 50 条

[41] Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
Irwin, David J.
Fedler, Janel
Coffey, Christopher S.
Caspell-Garcia, Chelsea
Kang, Ju Hee
Simuni, Tanya
Foroud, Tatiana
Toga, Arthur W.
Tanner, Caroline M.
Kieburtz, Karl
Chahine, Lana M.
Reimer, Alyssa
Hutten, Samantha
Weintraub, Daniel
Mollenhauer, Brit
Galasko, Douglas R.
Siderowf, Andrew
Marek, Kenneth
Trojanowski, John Q.
Shaw, Leslie M.
ANNALS OF NEUROLOGY, 2020, 88 (03) : 574 - 587
[42] Cerebrospinal fluid biomarkers in Alzheimer's disease, Parkinson's disease and atypical parkinsonism
Stojmenovic, G. Mandic
Markovic, I.
Stojkovic, T.
Despotovic, I.
Lukic, M. Jecmenica
Stefanova, E.
Kostic, V.
MOVEMENT DISORDERS, 2012, 27 : S386 - S386
[43] Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer's disease
Kuo, Hung-Chou
Yen, Hsiu-Chuan
Huang, Chin-Chang
Hsu, Wen-Chuin
Wei, Hsing-Ju
Lin, Chih-Lung
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2015, 125 (10) : 747 - 754
[44] Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
Schindler, Suzanne E.
Li, Yan
Todd, Kaitlin W.
Herries, Elizabeth M.
Henson, Rachel L.
Gray, Julia D.
Wang, Guoqiao
Graham, Danielle L.
Shaw, Leslie M.
Trojanowski, John Q.
Hassenstab, Jason J.
Benzinger, Tammie L. S.
Cruchaga, Carlos
Jucker, Mathias
Levin, Johannes
Chhatwal, Jasmeer P.
Noble, James M.
Ringman, John M.
Graff-Radford, Neill R.
Holtzman, David M.
Ladenson, Jack H.
Morris, John C.
Bateman, Randall J.
Xiong, Chengjie
Fagan, Anne M.
ALZHEIMERS & DEMENTIA, 2019, 15 (05) : 655 - 665
[45] Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis
Bjerke, Maria
Engelborghs, Sebastiaan
JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1199 - 1209
[46] Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update
Portelius, Erik
Brinkmalm, Gunnar
Pannee, Josef
Zetterberg, Henrik
Blennow, Kaj
Dahlen, Rahil
Brinkmalm, Ann
Gobom, Johan
EXPERT REVIEW OF PROTEOMICS, 2017, 14 (11) : 1007 - 1020
[47] Standardized multiparameter quantification of biomarkers for Alzheimer's disease in cerebrospinal fluid
Vanderstichele, H
Demeyer, L
De Roo, K
Van Remoortere, S
Mortier, V
Olsson, A
Vandecasteele, L
Kostanjevecki, V
Blennow, K
Vanmechelen, E
New Trends in Alzheimer and Parkinson Related Disorders: ADPD 2005, 2005, : 183 - 189
[48] Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease
Leuzy, Antoine
Cullen, Nicholas C.
Mattsson-Carlgren, Niklas
Hansson, Oskar
CURRENT OPINION IN NEUROLOGY, 2021, 34 (02) : 266 - 274
[49] Cerebrospinal Fluid Profiles of Amyloid β-Related Biomarkers in Alzheimer’s Disease
Christoffer Rosén
Ulf Andreasson
Niklas Mattsson
Jan Marcusson
Lennart Minthon
Niels Andreasen
Kaj Blennow
Henrik Zetterberg
NeuroMolecular Medicine, 2012, 14 : 65 - 73
[50] Cerebrospinal Fluid Profiles of Amyloid β-Related Biomarkers in Alzheimer's Disease
Rosen, Christoffer
Andreasson, Ulf
Mattsson, Niklas
Marcusson, Jan
Minthon, Lennart
Andreasen, Niels
Blennow, Kaj
Zetterberg, Henrik
NEUROMOLECULAR MEDICINE, 2012, 14 (01) : 65 - 73

← 1 2 3 4 5 →